Normal proinsulin processing despite beta-cell dysfunction in persistent hyperinsulinaemic hypoglycaemia of infancy (nesidioblastosis)

被引:9
|
作者
Leibowitz, G
Weintrob, N
Pikarsky, A
Josefsberg, Z
Landau, H
Glaser, B
Hales, CN
Cerasi, E
机构
[1] HADASSAH UNIV HOSP,DEPT ENDOCRINOL & METAB,MED CTR,IL-91120 JERUSALEM,ISRAEL
[2] SCHNEIDER CHILDRENS MED CTR ISRAEL,INST PEDIAT & ADOLESCENT ENDOCRINOL,PETAH TIQWA,ISRAEL
[3] HEBREW UNIV JERUSALEM,HADASSAH MED CTR,DEPT PEDIAT,JERUSALEM,ISRAEL
[4] ADDENBROOKES HOSP,DEPT CLIN BIOCHEM,CAMBRIDGE,ENGLAND
关键词
nesidioblastosis hypoglycaemia; infancy; proinsulin; pancreatectomy;
D O I
10.1007/s001250050580
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Persistent hyperinsulinaemic hypoglycaemia of infancy (PHHI) is a genetic disorder which causes severe hypoglycaemia in the neonate, The beta cells fail to respond to changes in blood glucose levels in all the stages of the disease, which often ends with NIDDM. Fasting insulin, intact proinsulin and des 31,32 split proinsulin levels were measured in PHHI patients with active disease, patients after partial pancreatectomy, and those in clinical remission. All but one of the pancreatectomized patients developed diabetes and were hyperglycaemic on evaluation. Fasting insulin was comparable in pancreatectomized and medically treated patients. Des 31,32 split proinsulin levels were much higher in pancreatectomized compared to non-pancreatectomized patients (10.7 +/- 2.5 vs 3.4, +/- 0.8 pmol/l, p = 0.001) and age-matched control subjects (3.8 +/- 1.4 pmol/l, p = 0.018). Also the ratio of des 31,32 split proinsulin to total insulin plus proinsulin-like peptides was higher in pancreatectomized patients (18.7 +/- 2.8 vs 7.2 +/- 0.8 % in non-pancreatectomized patients, p = 0.001, and 6.8 +/- 2.1 % in normal control subjects, p = 0.004). Furthermore, des 31,32 split: proinsulin was the dominating species of proinsulin-like molecules in the pancreatectomized patients (62.7 +/- 1.6 % vs 45.5 +/- 3.8 %, and 49.0 +/- 3.2 % in non-pancreatectomized patients and control subjects, respectively, p = 0.001 and p = 0.0002), Intact proinsulin levels, and the proinsulin percentage, tended to be higher in pancreatectomized patients, however, the differences did not reach statistical significance. All parameters were similar in non-pancreatectomized patients and age-matched control subjects. Subgroup analysis showed comparable proinsulin-like peptide levels in patients with active disease and those in apparent clinical remission. Fasting levels of insulin and proinsulin-like peptides were also measured in a larger group of healthy children and young adults. Insulin and des 31,32 split: proinsulin increased with age, the differences being most prominent when the young age group (0-8 years) was compared to the older groups (8-16 and > 16 years). The fasting levels of plasma insulin were correlated with those of intact proinsulin and des 31,32 split proinsulin (r = 0.82 and 0.81, respectively). Fasting insulin, intact proinsulin and des 31,32 split proinsulin were correlated with BMI (r = 0.55, 0.56 and 0.53, respectively). In summary, relative hyperproinsulinaemia was noted only in PHHI patients with increased secretory demand following pancreatectomy, but not in patients with active disease or those in spontaneous clinical remission. These findings suggest that abnormal proinsulin processing is not an intrinsic feature of PHHI despite the severe beta-cell dysfunction.
引用
收藏
页码:1338 / 1344
页数:7
相关论文
共 30 条
  • [1] Persistent hyperinsulinaemic hypoglycaemia of infancy (nesidioblastosis): a report from Kuwait
    Ramadan, DG
    Badawi, MH
    Zaki, M
    El Mazidi, Z
    Ismail, EAR
    El Anzi, H
    ANNALS OF TROPICAL PAEDIATRICS, 1999, 19 (01): : 55 - 59
  • [2] Persistent hyperinsulinaemic hypoglycaemia of infancy: a heterogeneous syndrome unrelated to nesidioblastosis
    Rahier, J
    Guiot, Y
    Sempoux, C
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2000, 82 (02): : F108 - F112
  • [3] Normal proinsulin processing despite dysfunction in persistent hyperinsulinemic hypoglycemia of infancy.
    Leibowitz, G
    Weintrob, N
    Pikarsky, A
    Landau, H
    Hales, CN
    Glaser, B
    Cerasi, E
    DIABETES, 1996, 45 : 1172 - 1172
  • [4] Impaired expression of transcription factor IUF1 in a pancreatic beta-cell line derived from a patient with persistent hyperinsulinaemic hypoglycaemia of infancy (nesidioblastosis)
    Macfarlane, WM
    Cragg, H
    Docherty, HM
    Read, ML
    James, RFL
    AynsleyGreen, A
    Docherty, K
    FEBS LETTERS, 1997, 413 (02) : 304 - 308
  • [5] HYPOGLYCEMIA IN INFANCY CAUSED BY BETA-CELL NESIDIOBLASTOSIS
    GRAMPA, G
    GARGANTINI, L
    GRIGOLATO, PG
    CHIUMELLO, G
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1974, 128 (02): : 226 - 231
  • [6] ELEVATED SERUM PROINSULIN IN BETA-CELL NESIDIOBLASTOSIS - REPORT OF A CASE IN A NEWBORN
    KUHL, C
    HVORSLEV, V
    TYGSTRUP, I
    LINDKAERJENSEN, S
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1979, 14 : 49 - 52
  • [7] Histochemical, clinical, and in vitro β cell responses in a neonate with persistent hyperinsulinaemic hypoglycaemia of infancy
    Panesar, NS
    Poon, CW
    Liew, CT
    Wong, GWK
    Hjelm, NM
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1998, 79 (02): : F141 - F144
  • [8] RAISED PROINSULIN CONCENTRATION AS EARLY INDICATOR OF BETA-CELL DYSFUNCTION
    WILLIAMS, DRR
    BYRNE, C
    CLARK, PMS
    COX, L
    DAY, NE
    RAYMAN, G
    WANG, T
    HALES, CN
    BRITISH MEDICAL JOURNAL, 1991, 303 (6794): : 95 - 96
  • [9] Proinsulin as a Potential Marker of Early Pancreatic Beta-Cell Dysfunction
    Nakamura, Akinobu
    Miyoshi, Hideaki
    Ukawa, Shigekazu
    Nakamura, Koshi
    Nakagawa, Takafumi
    Terauchi, Yasuo
    Tamakoshi, Akiko
    Atsumi, Tatsuya
    DIABETES, 2019, 68
  • [10] HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY (NESIDIOBLASTOSIS) IN CLINICAL REMISSION - HIGH-INCIDENCE OF DIABETES-MELLITUS AND PERSISTENT BETA-CELL DYSFUNCTION AT LONG-TERM FOLLOW-UP
    LEIBOWITZ, G
    GLASER, B
    HIGAZI, AA
    SALAMEH, M
    CERASI, E
    LANDAU, H
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (02): : 386 - 392